Lonza Group AG LON.N-CH:Swiss Exchange

*Data is delayed | Exchange | CHF
Last | 11/25/22 CET
503.20UNCH (UNCH)
52 week range
436.80 - 771.60
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close503.20
  • 52 Week High771.60
  • 52 Week High Date12/27/21
  • 52 Week Low436.80
  • 52 Week Low Date09/23/22

Key Stats

  • Market Cap39,630.5M
  • Shares Out74.19M
  • 10 Day Average Volume157,614.92
  • Dividend3.00
  • Dividend Yield0.60%
  • Beta0.99
  • YTD % Change-33.93

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close503.20
  • 52 Week High771.60
  • 52 Week High Date12/27/21
  • 52 Week Low436.80
  • 52 Week Low Date09/23/22
  • Market Cap39,630.5M
  • Shares Out74.19M
  • 10 Day Average Volume157,614.92
  • Dividend3.00
  • Dividend Yield0.60%
  • Beta0.99
  • YTD % Change-33.93

RATIOS/PROFITABILITY

  • EPS (TTM)41.87
  • P/E (TTM)12.02
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Lonza Group AG

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life science industries. The Company's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The Company divides its activities into two segments: Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech comprises the Company's Biologics...
Albert Baehny
Independent Chairman of the Board
Pierre-Alain Ruffieux Ph.D.
Chief Executive Officer, Member of the Executive Committee
Philippe Deecke
Chief Financial Officer, Member of the Executive Committee
Address
Muenchensteinerstrasse 38
Basel
4002
Switzerland